Recombinant adenoviral-meditated alterations of cytochrome P450 3A2 and 2C11
dc.contributor.advisor | Croyle, Maria A. | en |
dc.creator | Callahan, Shellie Marie | en |
dc.date.accessioned | 2008-08-28T22:18:40Z | en |
dc.date.accessioned | 2017-05-11T22:16:45Z | |
dc.date.available | 2008-08-28T22:18:40Z | en |
dc.date.available | 2017-05-11T22:16:45Z | |
dc.date.issued | 2005 | en |
dc.description | text | en |
dc.description.department | Pharmacy | en |
dc.format.medium | electronic | en |
dc.identifier | b60167609 | en |
dc.identifier.oclc | 62260114 | en |
dc.identifier.proqst | 3187676 | en |
dc.identifier.uri | http://hdl.handle.net/2152/1817 | en |
dc.language.iso | eng | en |
dc.rights | Copyright is held by the author. Presentation of this material on the Libraries' web site by University Libraries, The University of Texas at Austin was made possible under a limited license grant from the author who has retained all copyrights in the works. | en |
dc.subject.lcsh | Cytochrome P-450 | en |
dc.subject.lcsh | Drugs--Metabolism | en |
dc.title | Recombinant adenoviral-meditated alterations of cytochrome P450 3A2 and 2C11 | en |
dc.type.genre | Thesis | en |